Pharmather Holdings Valuation
| PHRRF Stock | USD 0.18 0.01 5.88% |
Pharmather Holdings seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Pharmather Holdings from analyzing the company fundamentals such as Return On Equity of -0.63, shares outstanding of 88.17 M, and Shares Owned By Institutions of 0.06 % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support locking in undervalued entities and disposing overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Pharmather Holdings' price fluctuation is out of control at this time. Calculation of the real value of Pharmather Holdings is based on 3 months time horizon. Increasing Pharmather Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pharmather otc stock is determined by what a typical buyer is willing to pay for full or partial control of Pharmather Holdings. Since Pharmather Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharmather OTC Stock. However, Pharmather Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.18 | Real 0.16 | Hype 0.18 | Naive 0.18 |
The real value of Pharmather OTC Stock, also known as its intrinsic value, is the underlying worth of Pharmather Holdings OTC Stock, which is reflected in its stock price. It is based on Pharmather Holdings' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pharmather Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pharmather Holdings helps investors to forecast how Pharmather otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharmather Holdings more accurately as focusing exclusively on Pharmather Holdings' fundamentals will not take into account other important factors: Pharmather Holdings Total Value Analysis
Pharmather Holdings is at this time projected to have takeover price of (3.24 M) with market capitalization of 13.44 M, debt of , and cash on hands of 10.15 M. The negative valuation of Pharmather Holdings may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Pharmather Holdings fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(3.24 M) | 13.44 M | 10.15 M |
Pharmather Holdings Asset Utilization
One of the ways to look at asset utilization of Pharmather is to check how much profit was generated for every dollar of assets it reports. Pharmather Holdings holds a negative application of assets of -0.25 pct., losing $0.002465 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Pharmather Holdings shows how discouraging it operates for each dollar spent on its assets.Pharmather Holdings Ownership Allocation
Pharmather Holdings owns a total of 88.17 Million outstanding shares. Pharmather Holdings holds 18.67 pct. of its outstanding shares held by insiders and 0.057 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pharmather Holdings Profitability Analysis
Net Loss for the year was (4.01 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pharmather Holdings' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pharmather Holdings and how it compares across the competition.
About Pharmather Holdings Valuation
The otc valuation mechanism determines Pharmather Holdings' current worth on a weekly basis. Our valuation model uses a comparative analysis of Pharmather Holdings. We calculate exposure to Pharmather Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharmather Holdings's related companies.PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company was incorporated in 2019 and is headquartered in Toronto, Canada. Pharmather Hldgs is traded on OTC Exchange in the United States.
8 Steps to conduct Pharmather Holdings' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Pharmather Holdings' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pharmather Holdings' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pharmather Holdings' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pharmather Holdings' revenue streams: Identify Pharmather Holdings' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pharmather Holdings' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pharmather Holdings' growth potential: Evaluate Pharmather Holdings' management, business model, and growth potential.
- Determine Pharmather Holdings' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pharmather Holdings' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pharmather Holdings Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pharmather Holdings does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 88.2 M | |
| Retained Earnings | -1.4 M |
Complementary Tools for Pharmather OTC Stock analysis
When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |